Static Chart Perspective Therapeutics, Inc.

Stocks

Real-time Estimate Cboe BZX Other stock markets 18:59:41 03/08/2026 +04			5-day change	1st Jan Change
3.000 ^USD	+3.09%		+6.38%	+9.09%

07-28	Perspective Therapeutics' Neuroendocrine Tumor Therapy Receives EU Orphan Drug Designation	MT
07-17	Perspective Therapeutics Data On 212Pb VMT-a-NET Accepted For Oral Presentation At ESMO Congress 2026	CI

Duration

Period